Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01056718 · ClinicalTrials.gov registry record · NA
Effects of Nebivolol on Exercise Tolerance and Left Ventricular Systolic and Diastolic Function
A NA study, sponsored by Mercy Research.
- Completed
- Registry status
- NA
- Development phase
- 53
- Enrollment target
NCT01056718 is a NA study that has completed, run by Mercy Research. The registered enrollment target is 53 participants.
The verdict
NCT01056718, a NA study, has completed, sponsored by Mercy Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 53 participants
- Enrollment target
Study Summary
The goal of this pilot study is to effectively treat hypertension in subjects with either known or newly diagnosed hypertension and concurrent evidence of diastolic dysfunction. Due to the unique properties of nebivolol, it is hypothesized that there will be improvements in left ventricular (LV) systolic and diastolic function manifesting as increase exercise capacity in this patient population with primarily LV diastolic dysfunction. The present study was performed to determine the effects of nebivolol on blood pressure, exercise tolerance and parameters of left ventricular systolic and diastolic function in a group of hypertensive patients with echocardiographic evidence diastolic dysfunction.
Interventions
- DRUG Nebivolol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2009-11 |
| Est. Completion | 2014-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01056718
The ClinicalTrials.gov registry entry for NCT01056718 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mercy Research, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nebivolol is the first listed.
NCT01056718 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01056718 about?
NCT01056718 is a clinical study titled "Effects of Nebivolol on Exercise Tolerance and Left Ventricular Systolic and Diastolic Function". The goal of this pilot study is to effectively treat hypertension in subjects with either known or newly diagnosed hypertension and concurrent evidence of diastolic dysfunction. Due to the unique properties of nebivolol, it is hypothesized that there will be improvements in left ventricular (LV) sys...
What is the current status of trial NCT01056718?
This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2009-11. Estimated completion is 2014-05.
What interventions are being tested in trial NCT01056718?
The interventions under investigation include: Nebivolol (DRUG).
Who is sponsoring clinical trial NCT01056718?
This trial is sponsored by Mercy Research, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.